Viral Capsid Protein Stoichiometry Using HILIC Mass Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing viral particle homogeneity, such as AAV, do not provide sufficient resolution for quantifying homogeneity in clinical-grade viral vector preparations, which is crucial for ensuring product quality and consistency in gene therapy.
Innovation Solution
A method involving hydrophilic interaction liquid chromatography (HILIC) is used to separate and determine the masses of protein components of viral capsids, allowing for the identification of stoichiometry and heterogeneity by comparing the masses with theoretical values.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If classic techniques such as electron microscopy and Southern Blots are used to characterize viral particle heterogeneity, then the characterization can be performed, but the resolution is insufficient for quantifying homogeneity in clinical-grade viral vector preparations
Solution Approach 1:
The patent changes the fundamental parameters of the analysis by using HILIC chromatography coupled with mass spectrometry instead of traditional methods. This approach measures the mass-to-charge ratio of capsid proteins with high precision, enabling quantitative assessment of viral particle homogeneity at the single-particle level, thereby resolving the contradiction between measurement precision and device complexity
Solution Approach 2:
The patent replaces mechanical visualization methods (electron microscopy) and hybridization techniques (Southern Blots) with a mass spectrometry-based system. This substitution enables direct measurement of capsid protein masses and stoichiometry, achieving superior resolution for homogeneity quantification without the limitations of traditional mechanical or chemical methods
2Reliability
If complete characterization of constituent viral capsid proteins including sequences and post-translational modifications is performed, then product quality and consistency can be ensured, but the analysis time and complexity increase
Solution Approach 1:
The patent performs preliminary separation of capsid proteins using HILIC chromatography before mass spectrometry analysis. This preliminary action resolves complex protein mixtures into distinct components based on their hydrophilic interactions, enabling subsequent rapid and accurate mass measurement and stoichiometry determination, thereby ensuring product quality without excessive analysis time
Solution Approach 2:
The patent segments the viral capsid protein mixture into individual components through HILIC chromatography separation. By dividing the complex sample into resolvable peaks corresponding to different capsid proteins and their modifications, the system can efficiently characterize each component's mass and abundance, ensuring comprehensive quality assessment while maintaining reasonable analysis duration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides high-resolution separation and quantification of viral capsid proteins, enabling accurate determination of stoichiometry and heterogeneity, thereby ensuring the quality and consistency of viral vectors for gene therapy applications.
Implementation Method 1
subjecting a sample of viral particles to hydrophilic interaction liquid chromatography (HILIC) to separate the protein components of the viral capsid
Implementation Method 2
determining the masses of protein components of the viral capsid to identify the protein components separated by HILIC
Data Source
AI summary
Methods of determining the stoichiometry of a viral capsid and/or determining the heterogeneity of protein components in a viral capsid are described.